Stay updated on Celecoxib Impact on SMN2 in SMA Clinical Trial
Sign up to get notified when there's something new on the Celecoxib Impact on SMN2 in SMA Clinical Trial page.

Latest updates to the Celecoxib Impact on SMN2 in SMA Clinical Trial page
- Check4 days agoChange DetectedNo significant changes detected; only minor visual/layout tweaks with no impact on core content or function. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check11 days agoNo Change Detected
- Check33 days agoChange Detected- Replaced the specific term 'Proximal spinal muscular atrophy' with the broader 'Spinal muscular atrophy' and incremented the revision version from v3.1.0 to v3.2.0. - Added a government-operations notice about funding, status, and references to cc.nih.gov and opm.gov. - The content now includes a general operating-status update rather than a prior more specific term.SummaryDifference4%

- Check40 days agoChange Detected- Updated version from v3.0.2 to v3.1.0. - No other content changes detected.SummaryDifference0.1%

- Check54 days agoChange DetectedRevision updated from v3.0.1 to v3.0.2. Removed the 'Back to Top' link.SummaryDifference0.3%

- Check61 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content.SummaryDifference0.3%

- Check69 days agoChange DetectedThe web page has undergone significant changes, including the addition of a facility name and location, while removing various medical terms and conditions related to neuromuscular diseases.SummaryDifference6%

Stay in the know with updates to Celecoxib Impact on SMN2 in SMA Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Celecoxib Impact on SMN2 in SMA Clinical Trial page.